Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05200182

fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Emotional overeating is characterized by an excessive food intake in the context of intense emotional situations, such as acute stress one. Emotional overeating, as a behavioral trait, can increase the risk of to develop eating disorders or eating-related diseases, such as metabolic syndrome, obesity, type-2 diabetes. Recently, imaging modalities, such as magnetic resonance imaging (MRI) and electro-encephalography (EEG), have been adapted in order to perform neurofeedback consisting on presenting the brain activity instantaneously to the participant, that give him the possibility to modify this activity by his own mean. Neurofeedback has already shown some efficacy, either with explicit or implicit instruction. Compared with functional MRI (fMRI), functional near infra-red spectroscopy (fNIRS) is easy to handle, less expensive, and does not require a lying position. fNIRS is consequently more adapted for repeated acquisitions. Neurofeedback has already shown some promising results for neurological and psychiatric diseases. For mental states and emotion regulation, neurofeedback targeting the prefrontal cortex (PFC) has also shown promising outcomes. In this project, the investigators want to assess the effect of neurofeedback targeting the dorsolateral PFC (dlPFC) in a population of young adult women presenting emotional overeating. The investigators aim to improve the cognitive control and to reduce the episodes of emotional overeating in order to prevent the occurrence of subsequent pathologies. The intervention effect will be characterized with: (i) fMRI in order to evaluate the effect on cognitive control (with resting state fMRI or rsMRI) and on the reward system; (II) questionaries directly and one month after intervention in order to assess the behavioral effect. Besides an expected effect on emotional overeating, the investigators will evaluate whether an improvement of cognitive control can also promote positive effect on other behavioral traits that could lead to some pathologies such as food addiction. As a prerequisite to this study on emotional overeating (study B), the investigators will firstly validate on healthy subjects (study A) a reward anticipation fMRI task, which will be further used in study A in order to characterized the effect of neurofeedback on the reward system.

Conditions

Interventions

TypeNameDescription
DEVICENeurofeedback with functional near infra-red spectroscopythe neurofeedback protocol will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dorsolateral prefrontal cortex using a visual gauge representing the "activity level" of his/her own dorsolateral prefrontal cortex. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".
DEVICESham Neurofeedbackthe participants will receive the same instruction but will be shown a random signal
OTHERoral microbiota collectionan examination and oral swab for oral microbiota analysis will be performed by a dentist
OTHERQuestionnairesquestionnaires for pre-intervention behavioral characterization
DEVICEresting-state fMRIcharacterize the brain function of volunteers by resting-state fMRI
DEVICEElectro gastrogramVolunteers will also be equipped with an MRI-compatible electro-gastrogram device to correlate gastric signals with brain activity during rsMRI acquisition.
BEHAVIORALEmotional Stroop taskan emotional Stroop task adapted to food and body image representation

Timeline

Start date
2022-04-07
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2022-01-20
Last updated
2024-04-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05200182. Inclusion in this directory is not an endorsement.